Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8. | Cancers (Basel) | 2023 | 37568638 | PubTator, text mining | PubMed |
| Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms. | Cancers (Basel) | 2023 | 37568631 | PubTator, text mining | PubMed |
| Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification. | Blood Cancer J | 2023 | 37558665 | PubTator, text mining | PubMed |
| Interplay of heavy chain introns influences efficient transcript splicing and affects product quality of recombinant biotherapeutic antibodies from CHO cells. | MAbs | 2023 | 37555672 | PubTator, text mining | PubMed |
| [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37550186 | PubTator, text mining | PubMed |
| Evaluation of new IPSS-Molecular model and comparison of different prognostic systems in patients with myelodysplastic syndrome. | Blood Sci | 2023 | 37546714 | PubTator, text mining | PubMed |
| Post-transcriptional regulation of erythropoiesis. | Blood Sci | 2023 | 37546708 | PubTator, text mining | PubMed |
| [RNA splicing dysregulation in hematological malignancies]. | Rinsho Ketsueki | 2023 | 37544725 | PubTator, text mining | PubMed |
| Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia. | J Hematol Oncol | 2023 | 37537667 | PubTator, text mining | PubMed |
| Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile. | Ann Hematol | 2023 | 37535147 | PubTator, text mining | PubMed |
| Efficacy and safety of avatrombopag in aplastic anemia patients with liver disease. | J Transl Int Med | 2023 | 37533842 | PubTator, text mining | PubMed |
| Pre-mRNA splicing-associated diseases and therapies. | RNA Biol | 2023 | 37528617 | PubTator, text mining | PubMed |
| A potential correlation between adipokines, skeletal muscle function and bone mineral density in middle-aged and elderly individuals. | Lipids Health Dis | 2023 | 37525169 | PubTator, text mining | PubMed |
| Early Splicing Complexes and Human Disease. | Int J Mol Sci | 2023 | 37511171 | PubTator, text mining | PubMed |
| Insights into the New Molecular Updates in Acute Myeloid Leukemia Pathogenesis. | Genes (Basel) | 2023 | 37510328 | PubTator, text mining | PubMed |
| Therapeutic Targeting of RNA Splicing in Cancer. | Genes (Basel) | 2023 | 37510283 | PubTator, text mining | PubMed |
| Genetic, Phenotypic, and Clinical Heterogeneity of NPM1-Mutant Acute Myeloid Leukemias. | Biomedicines | 2023 | 37509445 | PubTator, text mining | PubMed |
| Breaking the 'Undruggable' Barrier: Anti-PD-1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer Patients with KRAS Mutations-A Comprehensive Review and Description of Single Site Experience. | Cancers (Basel) | 2023 | 37509393 | PubTator, text mining | PubMed |
| The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score. | Cancers (Basel) | 2023 | 37509235 | PubTator, text mining | PubMed |
| High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis. | J Appl Genet | 2023 | 37507589 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=21